Last edition
News about "Roche IMAgINATION trial"
Roche's Sefaxersen Cuts Proteinuria in IgA Nephropathy
Roche’s sefaxersen significantly reduces proteinuria in IgA nephropathy, with Phase III IMAgINATION data showing meaningful results versus placebo.
Roche IMAgINATION Trial | 24/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members